
WEIGHT: 63 kg
Bust: Large
1 HOUR:50$
Overnight: +40$
Services: Rimming (receiving), Cross Dressing, Bondage, Trampling, Ass licking
The lunch lecture format offers the opportunity to exchange ideas with leading figures from translational research. What structures does a translational ecosystem need and what can we learn from international best practice examples?
How can the success of translation be measured and how can the scientific system implement appropriate criteria in order to entice researchers? Every two months at lunchtime on Fridays, the BIH invites an internationally renowned expert to give a lecture on these and other questions, followed by a discussion and networking with the community. Further information on this lecture.
His research focuses primarily on the ethics, politics and science of drug development. He spoke about the various benefits that trial participation can have for patients. He presented the evidence gathered by his research team and concluded by describing the key unresolved issues and some of the moral and policy implications of his analysis of the benefits of trials.
Video Presentation. On February 23, , Peter N. The bioinformatician is a pioneer in the computational genome and phenotype analysis of genetic diseases.
His major work has been the development of the Human Phenotype Ontology HPO , which is now a standard tool used globally to diagnose gene-related diseases. In his talk, Robinson reviewed their work in using HPO and other resources for computational precision medicine in rare and common disease. In the BIH Lecture on December 1, , Gordon Guyatt talked about the potentially misleading findings and interpretation of findings in the medical literature.